[go: up one dir, main page]

Hepatolenticular Degeneration

"Hepatolenticular Degeneration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.


expand / collapse Publications
This graph shows the total number of publications written about "Hepatolenticular Degeneration" by people in this website by year, and whether "Hepatolenticular Degeneration" was a major or minor topic of these publications.
Below are the most recent publications written about "Hepatolenticular Degeneration" by people in Profiles.
  1. The Genomic Landscape of Wilson Disease in a Pan India Disease Cohort and Population-Scale Data. Mov Disord Clin Pract. 2025 Feb; 12(2):185-195.
    View in: PubMed
  2. Hepatic oxylipin profiles in mouse models of Wilson disease: New insights into early hepatic manifestations. Biochim Biophys Acta Mol Cell Biol Lipids. 2024 03; 1869(2):159446.
    View in: PubMed
  3. The role of intestine in metabolic dysregulation in murine Wilson disease. Hepatol Commun. 2023 10 01; 7(10).
    View in: PubMed
  4. Wilson disease: a summary of the updated AASLD Practice Guidance. Hepatol Commun. 2023 06 01; 7(6).
    View in: PubMed
  5. Computed tomography of hyper-attenuated liver: Pictorial essay. Clin Imaging. 2023 May; 97:1-6.
    View in: PubMed
  6. A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2023 04 01; 77(4):1428-1455.
    View in: PubMed
  7. Monitoring and treatment of Wilson disease: progress and challenges. Lancet Gastroenterol Hepatol. 2022 12; 7(12):1063-1065.
    View in: PubMed
  8. Insights from Magnetic Evoked Field Analysis in Patients with Wilson's Disease. Neurol India. 2022 Sep-Oct; 70(5):1963-1970.
    View in: PubMed
  9. Functional tremor in Wilson's disease. Acta Neurol Belg. 2022 04; 122(2):561-563.
    View in: PubMed
  10. Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence. Biomolecules. 2021 08 20; 11(8).
    View in: PubMed